Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
0.2870
-0.0189 (-6.18%)
At close: Nov 20, 2026, 4:00 PM EST
0.2798
-0.0072 (-2.51%)
After-hours: Nov 20, 2026, 7:43 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $4.75 million as of November 20, 2026. It is the 44,818th most valuable company in the world and the 5,881st biggest in the United States. Its market cap has decreased by 77.49% in one year.
Market Cap
4.75M
Enterprise Value
11.11M
1-Year Change
-77.49%
Global Rank
Country Rank
#5,881 United States
Category
ChartMarket Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $4.75M, a decrease of -94.65%. That is a compound annual growth rate of -41.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 4.75M | -66.43% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XTL Biopharmaceuticals | 5.65M |
| SeaStar Medical Holding | 5.47M |
| Evogene | 5.47M |
| Cerenome | 5.36M |
| Acurx Pharmaceuticals | 5.27M |
| Kiora Pharmaceuticals | 5.25M |
| Alzamend Neuro | 5.02M |
| Cardio Diagnostics Holdings | 5.00M |